KRISTEN ROBINSON: Open Payments
NPI 1811207343 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 31 payments from 10 companies in 2025. Trend: 2023 $1,055 · 2024 $433 · 2025 $657
Food & beverage: $513Education: $144
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 7 | $191 |
| Lilly USA, LLC | 7 | $159 |
| Sumitomo Pharma America, Inc. | 5 | $98 |
| MILLICENT US INC | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $46 |
| Axsome Therapeutics, Inc. | 2 | $42 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Sage Therapeutics, LLC | 1 | $17 |
| ABBVIE INC. | 1 | $15 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $14 |
Products named: Veozah, ZEPBOUND, MYFEMBREE, MOUNJARO, TRINTELLIX, Auvelity, GEMTESA, FEMLYV.
Industry payments across LA — which companies pay providers there.
